In clinical trials, inhaled IFN-γ was demonstrated effective in the treatment of TB, but not in parenteral IFN-γ, which is likely due to the inactivation of gastrointestinal hydrolases, suggesting that aerosol therapy may effectively stimulate pulmonary macrophages [172]. The gene discussed is IFNG; the disease is tuberculosis.